Context Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.

CEO

Martin A. Lehr

CEOMartin A. Lehr

Employees

Employees12

Headquarters

Philadelphia, Pennsylvania

HeadquartersPhiladelphia, Pennsylvania

Founded

2015

Founded2015

Employees

Employees12

CNTX Key Statistics

Market cap

64.15M

Market cap64.15M

Price-Earnings ratio

-2.07

Price-Earnings ratio-2.07

Dividend yield

—

Dividend yield—

Average volume

78.44K

Average volume78.44K

High today

$0.7801

High today$0.7801

Low today

$0.7001

Low today$0.7001

Open price

$0.77

Open price$0.77

Volume

102.08K

Volume102.08K

52 Week high

$2.75

52 Week high$2.75

52 Week low

$0.55

52 Week low$0.55

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own CNTX. This list is generated using Robinhood data, and it’s not a recommendation.